Articles from Antidepressants

Doctors Welcome New Depression Drug, Cautiously - The New York Times

Doctors Welcome New Depression Drug, Cautiously  The New York TimesDoctors welcomed federal approval this week of a new, fast-acting nasal spray for depression. But also they expressed concerns about its cost and long-term ...

Stopping Or Changing Antidepressants May Take Much Longer Than Previous Recommendations, According To A New Report - Bustle

Stopping Or Changing Antidepressants May Take Much Longer Than Previous Recommendations, According To A New Report  BustleIf you take antidepressants, and you've tried, for whatever reason, to wean off your medication, you may have discovered that it takes more time than your doctor ...

The RAINBOW Trial: Integrated treatment for depression and obesity likely to have modest benefit - 2 Minute Medicine

The RAINBOW Trial: Integrated treatment for depression and obesity likely to have modest benefit  2 Minute Medicine1. In this randomized controlled trial, integrated behavioral weight loss treatment, problem-solving therapy, and as needed antidepressant treatment led to a.

Keep Medicare Part D's protected classes protected - The Independent | SUindependent.com

Keep Medicare Part D's protected classes protected  The Independent | SUindependent.comA proposed regulation would amend the six protected classes rule and allow insurers to exclude many drugs from Medicare Part D plans.

The Dark Horse of Depression that Followed My MG Diagnosis - Myasthenia Gravis News

The Dark Horse of Depression that Followed My MG Diagnosis  Myasthenia Gravis NewsColumnist Retha De Wet writes about her disappointment that when diagnosed, she wasn't warned of the depression that can accompany myasthenia gravis.

Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs - Zacks.com

Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs  Zacks.comJ&J's (JNJ) Spravato (esketamine) gets approval for treatment-resistant depression. CHMP recommends approval of several drugs.

Yale researchers bolster conversations on psychedelic science - Yale Daily News

Yale researchers bolster conversations on psychedelic science  Yale Daily NewsLong thought to be a recreational drug that only induces hallucinations, psychedelics are now being eyed by Western researchers as a therapeutic intervention ...

Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs - Nasdaq

Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs  NasdaqThis week, J&J JNJ gained FDA approval for its antidepressant, Spravato (esketamine). It was the first approval for a depression drug in decades. Lilly LLY said ...

Pages